Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan in Resistant Arterial Hypertension
NCT04388124Phase 2Recruiting
- Sponsor
- Rouen University Hospital
- Start
- Oct 2021
- Primary completion
- Aug 2026
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bosentan in resistant hypertension (RH), sponsored by Rouen University Hospital. Started Oct 2021; status: recruiting.
02
Drugs
bosentan
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NCT04388124.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04388124.